Media Relations Media Releases Study examining moral injury in health care workers is focusing on functional brain changes October 20, 2021 Biotech Support Group & Lawson Health Research Institute Enter Collaborative Research Agreement to Monitor Protease Inhibitor Function During COVID-19 Infections September 24, 2021 New form of expanded dialysis improves quality of life, study finds September 23, 2021 New tool to help Multiple Sclerosis patients with mental health challenges July 20, 2021 Research encourages re-evaluation of special nerve treatment for chronic pain July 8, 2021 A “safety net of relationships” to bridge the gap between hospital and community at discharge June 23, 2021 Study to examine health impacts of the COVID-19 pandemic for mothers and their new babies June 16, 2021 Reducing social isolation with new community resource June 2, 2021 London researchers team up with Diagnostics Biochem Canada to study COVID-19 May 25, 2021 New treatment for critically ill COVID-19 patients with sepsis is one step closer to potentially saving lives May 26, 2021 Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last » 2023 Media Releases 2022 Media Releases 2021 Media Releases 2020 Media Releases 2019 Media Releases 2018 Media Releases 2017 Media Releases 2016 Media Releases
Study examining moral injury in health care workers is focusing on functional brain changes October 20, 2021
Biotech Support Group & Lawson Health Research Institute Enter Collaborative Research Agreement to Monitor Protease Inhibitor Function During COVID-19 Infections September 24, 2021
A “safety net of relationships” to bridge the gap between hospital and community at discharge June 23, 2021
Study to examine health impacts of the COVID-19 pandemic for mothers and their new babies June 16, 2021
New treatment for critically ill COVID-19 patients with sepsis is one step closer to potentially saving lives May 26, 2021
May 31, 2024 Canadian researchers will test a promising new fecal microbiota treatment on patients to cure advanced melanoma